Financial Ratios AviChina Industry & Technology Company Limited
Equities
2357
CNE1000001Y8
Aerospace & Defense
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.860 HKD | -2.53% |
|
-4.93% | -2.77% |
| 06/02 | AviChina Industry & Technology says Aviation Industrial Fund to sell 3.7805% stake in Avic Jierui | RE |
| 06/02 | AviChina Unit to Buy 10% Stake in AVIC Jierui | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.02 | 2.45 | 1.95 | 2.04 | 1.73 | |||||
Return on Total Capital | 4.08 | 4.87 | 3.98 | 3.86 | 3.09 | |||||
Return On Equity % | 9.1 | 9.58 | 8.84 | 8.18 | 6.23 | |||||
Return on Common Equity | 9.31 | 9.5 | 8.06 | 7.96 | 6.66 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 20.88 | 20.4 | 21.91 | 24.58 | 21.12 | |||||
SG&A Margin | 13.61 | 6.75 | 7.12 | 7.79 | 6.88 | |||||
EBITDA Margin % | 10.22 | 10.65 | 9.41 | 9.93 | 9.46 | |||||
EBITA Margin % | 7.27 | 8.25 | 6.93 | 7.15 | 6.33 | |||||
EBIT Margin % | 7.21 | 8.1 | 6.83 | 7.02 | 6.18 | |||||
Income From Continuing Operations Margin % | 7.76 | 8.02 | 7.84 | 7.89 | 6.62 | |||||
Net Income Margin % | 3.98 | 3.93 | 3.48 | 2.89 | 2.52 | |||||
Net Avail. For Common Margin % | 3.98 | 3.93 | 3.48 | 2.89 | 2.52 | |||||
Normalized Net Income Margin | 0.99 | 1.3 | 0.33 | -0 | 0.1 | |||||
Levered Free Cash Flow Margin | -3.17 | -2.79 | 9.97 | -13.72 | -3.59 | |||||
Unlevered Free Cash Flow Margin | -2.56 | -2.38 | 10.41 | -13.42 | -3.29 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.45 | 0.48 | 0.46 | 0.47 | 0.45 | |||||
Fixed Assets Turnover | 2.62 | 3.33 | 3.51 | 3.27 | 3.05 | |||||
Receivables Turnover (Average Receivables) | 1.86 | 1.79 | 1.68 | 1.62 | 1.38 | |||||
Inventory Turnover (Average Inventory) | 1.32 | 1.52 | 1.49 | 1.6 | 1.76 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.47 | 1.51 | 1.46 | 1.69 | 1.66 | |||||
Quick Ratio | 0.91 | 0.89 | 0.93 | 1.1 | 1.16 | |||||
Operating Cash Flow to Current Liabilities | 0.01 | 0.03 | 0.13 | -0.05 | 0.02 | |||||
Days Sales Outstanding (Average Receivables) | 196.74 | 203.77 | 216.77 | 225.57 | 264.8 | |||||
Days Outstanding Inventory (Average Inventory) | 276.49 | 239.9 | 244.16 | 228.67 | 207.89 | |||||
Average Days Payable Outstanding | 270.86 | 259.53 | 281.91 | 281.72 | 295.79 | |||||
Cash Conversion Cycle (Average Days) | 202.37 | 184.13 | 179.02 | 172.51 | 176.9 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 27.15 | 21.39 | 20.29 | 15.84 | 19.13 | |||||
Total Debt / Total Capital | 21.35 | 17.62 | 16.87 | 13.67 | 16.06 | |||||
LT Debt/Equity | 12.84 | 13.1 | 4.88 | 8.38 | 5.92 | |||||
Long-Term Debt / Total Capital | 10.1 | 10.79 | 4.06 | 7.24 | 4.97 | |||||
Total Liabilities / Total Assets | 60.61 | 59.1 | 59.62 | 52.41 | 52.16 | |||||
EBIT / Interest Expense | 7.36 | 12.29 | 9.87 | 14.46 | 12.67 | |||||
EBITDA / Interest Expense | 10.67 | 16.35 | 13.72 | 20.69 | 19.66 | |||||
(EBITDA - Capex) / Interest Expense | 6.13 | 9.15 | 6.49 | 9.2 | 9.56 | |||||
Total Debt / EBITDA | 2.37 | 1.8 | 1.95 | 1.64 | 2.22 | |||||
Net Debt / EBITDA | -2.74 | -2.04 | -3.99 | -2.84 | -2.9 | |||||
Total Debt / (EBITDA - Capex) | 4.12 | 3.22 | 4.13 | 3.69 | 4.56 | |||||
Net Debt / (EBITDA - Capex) | -4.76 | -3.65 | -8.43 | -6.39 | -5.96 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 14.34 | 18.39 | 5.54 | 7.57 | 2.62 | |||||
Gross Profit, 1 Yr. Growth % | 8.62 | 22.3 | 13.36 | 13.66 | -11.02 | |||||
EBITDA, 1 Yr. Growth % | 11.75 | 21.62 | -8.92 | 0.56 | -8.22 | |||||
EBITA, 1 Yr. Growth % | 19.39 | 26.9 | -13.91 | -0.29 | -16.7 | |||||
EBIT, 1 Yr. Growth % | 19.94 | 32.04 | -11.39 | 3.63 | -14.42 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 39.01 | 27.29 | 3.22 | 13.89 | -14 | |||||
Net Income, 1 Yr. Growth % | 48.08 | 22.57 | -6.45 | 5.45 | -10.61 | |||||
Normalized Net Income, 1 Yr. Growth % | 14.4 | 20.41 | -74.45 | -100.29 | -65.69 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 48.34 | 22.8 | -6.51 | 3.32 | -11.9 | |||||
Accounts Receivable, 1 Yr. Growth % | 22.66 | 22.65 | 4.44 | 18.02 | 21.68 | |||||
Inventory, 1 Yr. Growth % | 5.18 | 5.41 | 5.37 | 0.44 | -5.77 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.9 | 7.26 | -6.32 | 10.29 | 9.24 | |||||
Total Assets, 1 Yr. Growth % | 7.63 | 15.77 | 7.56 | 3.29 | 9.17 | |||||
Tangible Book Value, 1 Yr. Growth % | 11.62 | 17.32 | 7.46 | 6.22 | 9.39 | |||||
Common Equity, 1 Yr. Growth % | 11.14 | 17.11 | 4.52 | 5.62 | 8.16 | |||||
Cash From Operations, 1 Yr. Growth % | -91.36 | 160.76 | 361.46 | -139.95 | -153.19 | |||||
Capital Expenditures, 1 Yr. Growth % | -3.75 | 19.62 | 11.38 | 11.8 | -9.49 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -116.46 | -59.73 | -480.6 | -493.71 | -72.67 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -112.74 | -62.79 | -566.53 | -446.24 | -74.41 | |||||
Dividend Per Share, 1 Yr. Growth % | 66.67 | 60 | 0 | 10 | -7.95 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 18.39 | 17.29 | 11.78 | 18.54 | 5.08 | |||||
Gross Profit, 2 Yr. CAGR % | 15.86 | 13.01 | 17.74 | 30.11 | 0.14 | |||||
EBITDA, 2 Yr. CAGR % | 12.15 | 18.4 | 6.5 | 13.11 | -0.81 | |||||
EBITA, 2 Yr. CAGR % | 11.23 | 27.64 | 6.11 | 8.71 | -4.8 | |||||
EBIT, 2 Yr. CAGR % | 11.61 | 27.33 | 8.4 | 10.13 | -3.25 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 22.93 | 31.42 | 14.63 | 17.62 | -1.02 | |||||
Net Income, 2 Yr. CAGR % | 24.57 | 32.62 | 7.08 | 1.63 | -2.91 | |||||
Normalized Net Income, 2 Yr. CAGR % | 5.67 | 34.38 | -42.79 | -96.19 | -55.11 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 9.54 | 32.86 | 7.14 | 0.65 | -4.59 | |||||
Accounts Receivable, 2 Yr. CAGR % | 12.75 | 22.65 | 13.18 | 23.92 | 19.87 | |||||
Inventory, 2 Yr. CAGR % | 14.46 | 5.29 | 5.39 | 11.32 | -2.71 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 11.74 | 0.66 | 0.24 | 20.5 | 9.8 | |||||
Total Assets, 2 Yr. CAGR % | 14.87 | 11.44 | 11.59 | 17.55 | 6.21 | |||||
Tangible Book Value, 2 Yr. CAGR % | 20.98 | 9.36 | 12.28 | 7.86 | 7.79 | |||||
Common Equity, 2 Yr. CAGR % | 14.05 | 15.14 | 10.64 | 8.32 | 6.88 | |||||
Cash From Operations, 2 Yr. CAGR % | -8.13 | -35.4 | 246.89 | 34.88 | -53.92 | |||||
Capital Expenditures, 2 Yr. CAGR % | 12.1 | 11.16 | 15.43 | 28.64 | 0.59 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -0.91 | -58.27 | 23.32 | 164 | 2.91 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 0.39 | -62.26 | 31.15 | 182.97 | -6.64 | |||||
Dividend Per Share, 2 Yr. CAGR % | 29.1 | 63.3 | 26.49 | 4.88 | 0.62 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 15.42 | 19.03 | 13.23 | 18.49 | 12.99 | |||||
Gross Profit, 3 Yr. CAGR % | 12.02 | 16.43 | 13.12 | 27.45 | 14.31 | |||||
EBITDA, 3 Yr. CAGR % | 10.74 | 16.41 | 9.34 | 16.8 | 7.77 | |||||
EBITA, 3 Yr. CAGR % | 10.19 | 19.08 | 13.07 | 15.62 | 2.42 | |||||
EBIT, 3 Yr. CAGR % | 10.57 | 18.97 | 12.99 | 17.17 | 3.09 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 17.21 | 23.36 | 21.25 | 20.76 | 5.98 | |||||
Net Income, 3 Yr. CAGR % | 17.74 | 22.6 | 18.05 | 8.18 | -2.63 | |||||
Normalized Net Income, 3 Yr. CAGR % | 8.68 | 20.79 | -21.12 | -87.7 | -53.47 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 7.99 | 12.61 | 18.17 | 7.55 | -3.72 | |||||
Accounts Receivable, 3 Yr. CAGR % | 19.16 | 15.96 | 16.25 | 23.5 | 23.19 | |||||
Inventory, 3 Yr. CAGR % | 9.77 | 11.36 | 5.32 | 9.32 | 5.31 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 10.83 | 5.78 | -1.72 | 15.92 | 16.65 | |||||
Total Assets, 3 Yr. CAGR % | 13.71 | 15.04 | 10.13 | 16.96 | 14.7 | |||||
Tangible Book Value, 3 Yr. CAGR % | 21.15 | 16.18 | 8.72 | 10.92 | 8.36 | |||||
Common Equity, 3 Yr. CAGR % | 15.31 | 15.77 | 11.49 | 11.17 | 8.27 | |||||
Cash From Operations, 3 Yr. CAGR % | -33.6 | 59.72 | 24.42 | 68.03 | -1.11 | |||||
Capital Expenditures, 3 Yr. CAGR % | 5.05 | 17.28 | 11.24 | 25.56 | 14.41 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 390.19 | 1.29 | -13.04 | 40.7 | 23.3 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 62.48 | 4.05 | -13 | 43.46 | 26.32 | |||||
Dividend Per Share, 3 Yr. CAGR % | 18.56 | 38.67 | 38.67 | 20.74 | 0.41 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.8 | 10.36 | 14.32 | 18.83 | 14.69 | |||||
Gross Profit, 5 Yr. CAGR % | 9.36 | 11.82 | 13.37 | 21.72 | 13.78 | |||||
EBITDA, 5 Yr. CAGR % | 8.32 | 12.11 | 9.7 | 15.63 | 12.43 | |||||
EBITA, 5 Yr. CAGR % | 7.53 | 13.38 | 10.13 | 15.51 | 12.52 | |||||
EBIT, 5 Yr. CAGR % | 7.57 | 13.36 | 10.21 | 15.45 | 12.27 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 11.9 | 16.02 | 15.61 | 21.03 | 15.5 | |||||
Net Income, 5 Yr. CAGR % | 11.78 | 15.35 | 12.64 | 13.74 | 10.18 | |||||
Normalized Net Income, 5 Yr. CAGR % | 1.75 | 13.36 | -11.24 | -69.31 | -27.99 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 6.13 | 9.61 | 6.97 | 7.66 | 9.52 | |||||
Accounts Receivable, 5 Yr. CAGR % | 14.18 | 17.54 | 16.73 | 19.08 | 22.98 | |||||
Inventory, 5 Yr. CAGR % | 9.06 | 8.38 | 8 | 11.35 | 5.3 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 11.35 | 6.71 | 3.86 | 11.44 | 9.97 | |||||
Total Assets, 5 Yr. CAGR % | 11.58 | 13.33 | 12.78 | 16.04 | 13.38 | |||||
Tangible Book Value, 5 Yr. CAGR % | 15.19 | 15.7 | 15.41 | 12.78 | 8.76 | |||||
Common Equity, 5 Yr. CAGR % | 12.24 | 14.28 | 13.84 | 12.73 | 10.97 | |||||
Cash From Operations, 5 Yr. CAGR % | -20.39 | 19.33 | 45.51 | 49.28 | -16.6 | |||||
Capital Expenditures, 5 Yr. CAGR % | 4.42 | 16.63 | 10.64 | 21.7 | 13.1 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 26.3 | -6.49 | 242.42 | 48.35 | -20.18 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 11.32 | -7.08 | 85.84 | 54.97 | -22.23 | |||||
Dividend Per Share, 5 Yr. CAGR % | 20.11 | 31.95 | 21.67 | 24.01 | 21.98 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















